COVID vaccines: time to confront anti-vax aggression.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

18 citing papers in PubMed.

1. Development of Methods to Produce SARS CoV-2 Virus-Like Particles at Scale.Biotechnology and bioengineering · 2025
   Article
2. Three-year COVID-19 and flu vaccinations among medical residents in a tertiary hospital in Italy: The threat of acceptance decline in seasonal campaigns.Human vaccines & immunotherapeutics · 2023
   Article
3. SARS-CoV-2 variants offer a second chance to fix vaccine inequities.Nature reviews. Microbiology · 2023
   Article
4. Pediatric COVID-19 Health Disparities and Vaccine Equity.Journal of the Pediatric Infectious Diseases Society · 2022
   Article
5. Mistrust in public health institutions is a stronger predictor of vaccine hesitancy and uptake than Trust in Trump.Social science & medicine (1982) · 2022
   Article
6. Treating Anti-Vax Patients, a New Occupational Stressor-Data from the 4th Wave of the Prospective Study of Intensivists and COVID-19 (PSIC).International journal of environmental research and public health · 2022
   Article
7. Brilacidin, a Non-Peptide Defensin-Mimetic Molecule, Inhibits SARS-CoV-2 Infection by Blocking Viral Entry.EC microbiology · 2022
   Article
8. Determinants of COVID-19 Vaccinations among a State-Wide Year-Long Surveillance Initiative in a Conservative Southern State.Vaccines · 2022
   Article
9. Communicating science and protecting scientists in a time of political instability.Trends in molecular medicine · 2022
   Article
10. The Coronavirus pandemic - 2022: Viruses, variants & vaccines.Cytokine & growth factor reviews · 2022
    Article
11. Does highlighting COVID-19 disparities reduce or increase vaccine intentions? evidence from a survey experiment in a diverse sample in New York State prior to vaccine roll-out.PloS one · 2022
    Article
12. Which hospital workers do (not) want the jab? Behavioral correlates of COVID-19 vaccine willingness among employees of Swiss hospitals.PloS one · 2022
    Article
13. Promoting COVID-19 vaccine acceptance: recommendations from the Lancet Commission on Vaccine Refusal, Acceptance, and Demand in the USA.Lancet (London, England) · 2021
    Review
14. The successful COVID-19 vaccine rollout in Chile: Factors and challenges.Vaccine: X · 2021
    Article
15. Global public health security and justice for vaccines and therapeutics in the COVID-19 pandemic.EClinicalMedicine · 2021
    Review
16. COVID-19 vaccine hesitancy among medical students in India.Epidemiology and infection · 2021
    Article
17. Targeting COVID-19 Vaccine Hesitancy in Minority Populations in the US: Implications for Herd Immunity.Vaccines · 2021
    Review
18. The Role of Influential Actors in Fostering the Polarized COVID-19 Vaccine Discourse on Twitter: Mixed Methods of Machine Learning and Inductive Coding.JMIR infodemiology
    Article

Corrections and comments

• Commented on by
  Boost vaccine confidence with trust, not ire.2021

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as